Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vesiculobullous Skin Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT01619670
What this trial is testing

A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa

Who this might be right for
Epidermolysis BullosaWound Healing
University Hospital, Basel, Switzerland 3
Not applicableUnknownNCT05534776
What this trial is testing

Validation of 5-Point Investigator Global Assessments for Pemphigus

Who this might be right for
Pemphigus
Premier Specialists, Australia 40
Testing effectiveness (Phase 2)Study completedNCT00380640
What this trial is testing

The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
The Hospital for Sick Children 10
Testing effectiveness (Phase 2)WithdrawnNCT01528306
What this trial is testing

A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Healthpoint
Very early researchStudy completedNCT02343783
What this trial is testing

Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants

Who this might be right for
Dermatitis, AtopicAsthmaHealthy
Janssen Research & Development, LLC 46
Not applicableUnknownNCT05390073
What this trial is testing

Growth Hormone in EB

Who this might be right for
Epidermolysis Bullosa Dystrophica
Cairo University 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07210554
What this trial is testing

Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid (BP)
Chengdu Kangnuoxing Biopharma,Inc. 200
Post-approval studies (Phase 4)UnknownNCT00815594
What this trial is testing

Bleb Vascularity Change After Subconjunctival Injection Bevacizumab

Who this might be right for
Bleb VascularityConjunctival Scarring
Capital Medical University 30
Large-scale testing (Phase 3)Study completedNCT00213512
What this trial is testing

Effect of Anti CD20 in Pemphigus Desease

Who this might be right for
Pemphigus
University Hospital, Rouen 22
Post-approval studies (Phase 4)Study completedNCT05406908
What this trial is testing

Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases

Who this might be right for
Bullous DermatosesPsoriasisCOVID-19 Vaccines
Mahidol University 109
Not applicableLooking for participantsNCT05954416
What this trial is testing

FARD (RaDiCo Cohort) (RaDiCo-FARD)

Who this might be right for
Inherited Epidermolysis BullosaIchthyosisEctodermal Dysplasia+6 more
Institut National de la Santé Et de la Recherche Médicale, France 900
Testing effectiveness (Phase 2)Ended earlyNCT03286582
What this trial is testing

A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid
TWi Biotechnology, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT00825565
What this trial is testing

Study of Alwextin® Cream in Treating Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Northwestern University 8
Testing effectiveness (Phase 2)Looking for participantsNCT07027345
What this trial is testing

A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis Bullosa Simplex
BioMendics, LLC 40
Testing effectiveness (Phase 2)Study completedNCT00656656
What this trial is testing

Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus

Who this might be right for
Pemphigus
University of Luebeck 23
Not applicableLooking for participantsNCT07700966
What this trial is testing

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics, Inc 250
Testing effectiveness (Phase 2)WithdrawnNCT02319616
What this trial is testing

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal Necrolysis
University of California, Davis
Post-approval studies (Phase 4)Study completedNCT02739295
What this trial is testing

G-CSF in the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Stevens - Johnson Syndrome
University of Liege 10
Large-scale testing (Phase 3)WithdrawnNCT04128176
What this trial is testing

Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid
University of California, Davis
Not applicableStudy completedNCT00844038
What this trial is testing

Stevens-Johnson Syndrome Antimicrobial

Who this might be right for
Stevens-Johnson Syndrome
University of Pernambuco 1
Next Page